ConductScience.org, home

Paper38175

National Cooperative Crohn's Disease Study: study design and conduct of the study.

Winship DH and 6 others. Gastroenterology, 1979. Cited by 137 papers, by iCite.

Cite this record

ConductScience Library. National Cooperative Crohn's Disease Study: study design and conduct of the study. Papers, record 38175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38175

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
National Cooperative Crohn's Disease Study: study design and conduct of the study.
PubMed
Journal
Gastroenterology
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
137
iCite
Relative citation ratio, by iCite
4.32
iCite
Revised in PubMed
2013-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Winship DHD H
2Summers RWR W
3Singleton JWJ W
4Best WRW R
5Becktel JMJ M
6Lenk LFL F
7Kern F JrF

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Crohn DiseaseMajor topic
Azathioprine
Clinical Trials as Topic
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Male
Prednisone
Random Allocation
Recurrence
Research Design
Sulfasalazine
United States

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.

PMIDTitleJournalYearIn PapersSource
42232212Impact of Paediatric-Onset Inflammatory Bowel Disease on Educational Paths and Careers.Inflamm Intest Dis2026https://conductscience.org/library/papers/42232212PubMed
40971924Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.Inflamm Bowel Dis2025https://conductscience.org/library/papers/40971924PubMed
39055374HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn's disease.Gastroenterol Rep (Oxf)2024https://conductscience.org/library/papers/39055374PubMed
38667499Fecal Calprotectin in Patients with Crohn's Disease: A Study Based on the History of Bowel Resection and Location of Disease.Diagnostics (Basel)2024https://conductscience.org/library/papers/38667499PubMed
35664492Venlafaxine as an Adjuvant Therapy for Inflammatory Bowel Disease Patients With Anxious and Depressive Symptoms: A Randomized Controlled Trial.Front Psychiatry2022https://conductscience.org/library/papers/35664492PubMed
32994692Updated bone mineral density status in Saudi patients with inflammatory bowel disease.World J Gastroenterol2020https://conductscience.org/library/papers/32994692PubMed
32382271Work Productivity Loss in Inflammatory Bowel Disease Patients in Turkey.Gastroenterol Res Pract2020https://conductscience.org/library/papers/32382271PubMed
31636478Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.World J Gastroenterol2019https://conductscience.org/library/papers/31636478PubMed
31512092Altered sleep quality is associated with Crohn's disease activity: an actimetry study.Sleep Breath2020https://conductscience.org/library/papers/31512092PubMed
31102158Patient and general population values for luminal and perianal fistulising Crohn's disease health states.Eur J Health Econ2019https://conductscience.org/library/papers/31102158PubMed
30225788Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.Qual Life Res2019https://conductscience.org/library/papers/30225788PubMed
28670235Ophthalmologic manifestations in patients with inflammatory bowel disease.Intest Res2017https://conductscience.org/library/papers/28670235PubMed
28228435Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab.BMJ Case Rep2017https://conductscience.org/library/papers/28228435PubMed
27783843Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27783843PubMed
27472702Factors affecting poor nutritional status after small bowel resection in patients with Crohn disease.Medicine (Baltimore)2016https://conductscience.org/library/papers/27472702PubMed
27149857Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.BMC Med Imaging2016https://conductscience.org/library/papers/27149857PubMed
26523111Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?World J Gastroenterol2015https://conductscience.org/library/papers/26523111PubMed
26039678Budesonide for induction of remission in Crohn's disease.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26039678PubMed
25772778Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.Dig Dis Sci2015https://conductscience.org/library/papers/25772778PubMed
22644337
Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype.
J Gastroenterol2012https://conductscience.org/library/papers/22644337PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38175

GET https://conductscience.org/api/papers/v1/38175/cited_by?page=2